Patents by Inventor Alexis Gautreau

Alexis Gautreau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160199445
    Abstract: The present invention relates to the diagnostic and therapeutic uses of Arpin, a protein from the Uncharacterized Protein Family UPF0552, which is a new inhibitor of the Arp2/3 that inhibits cell migration and is associated with the prognosis of cancer.
    Type: Application
    Filed: September 2, 2014
    Publication date: July 14, 2016
    Inventors: Alexis GAUTREAU, Antonina ALEXANDROVA, Sophie VACHER, Carla SOUSA-BLIN, Emmanuel DERIVERY, Roman GORELIK
  • Publication number: 20020115633
    Abstract: The invention relates to a pharmaceutical composition containing an effective amount of ezrin mutated on tyrosine 353, or a functional fragment or derivative thereof, in association with a pharmaceutically acceptable carrier, for use preferably in the prevention and/or treatment of tumors.
    Type: Application
    Filed: April 8, 2002
    Publication date: August 22, 2002
    Applicant: Institute Curie
    Inventors: Monique Arpin, Tiziana Crepaldi, Alexis Gautreau, Daniel Louvard
  • Patent number: 6399584
    Abstract: The invention relates to a pharmaceutical composition containing an effective amount of ezrin mutated on tyrosine 353, or a functional fragment or derivative thereof, in association with a pharmaceutically acceptable carrier, for use preferably in the prevention and/or treatment of tumors.
    Type: Grant
    Filed: March 18, 1998
    Date of Patent: June 4, 2002
    Assignees: Institute Curie, Centre National de Recherche Scientfique
    Inventors: Monique Arpin, Tiziana Crepaldi, Alexis Gautreau, Daniel Louvard